Source:http://linkedlifedata.com/resource/pubmed/id/20826914
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2010-9-9
|
pubmed:abstractText |
14-3-3 sigma (?) induces G2 arrest enabling the repair of damaged DNA. The function of 14-3-3 ? is frequently lost in tumor cells, indicating a potential tumor suppressor function. The purpose of this study was to evaluate the prognostic value of 14-3-3 ? expression in human gastric cancer. 14-3-3 ? expression was analyzed by immunohistochemistry in 157 tumor samples of patients, who underwent resection for gastric cancer. Since 14-3-3 ? is involved in the p53 network, p53 expression was detected in parallel and correlated with 14-3-3 ?. 14-3-3 ? was found to be overexpressed in 75 (47.8%) of 157 cases, the overexpression rate of p53 protein was 27.4%. 14-3-3 ? overexpression was statistically significantly associated with pT-stage (p=0.041) pN-stage (p=0.015) and UICC-stage (p=0.019) and showed a borderline significance with Lauren classification (p=0.057). Univariate survival calculations revealed a coexistent 14-3-3 ? and p53 overexpression as a significant predictor of disease-free survival. Multivariate analysis did not unfold 14-3-3 as an independent prognostic factor for disease-free survival and overall survival. Concomitant 14-3-3 ? and p53 overexpression in tumor cells of patients with gastric cancer identifies a population of patients with relatively unfavorable prognosis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/14-3-3 Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Exonucleases,
http://linkedlifedata.com/resource/pubmed/chemical/SFN protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Protein p53
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1875-8630
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
29
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
21-9
|
pubmed:dateRevised |
2011-1-7
|
pubmed:meshHeading |
pubmed-meshheading:20826914-14-3-3 Proteins,
pubmed-meshheading:20826914-Adult,
pubmed-meshheading:20826914-Aged,
pubmed-meshheading:20826914-Aged, 80 and over,
pubmed-meshheading:20826914-Exonucleases,
pubmed-meshheading:20826914-Female,
pubmed-meshheading:20826914-Humans,
pubmed-meshheading:20826914-Immunohistochemistry,
pubmed-meshheading:20826914-Male,
pubmed-meshheading:20826914-Middle Aged,
pubmed-meshheading:20826914-Stomach Neoplasms,
pubmed-meshheading:20826914-Survival Analysis,
pubmed-meshheading:20826914-Tumor Markers, Biological,
pubmed-meshheading:20826914-Tumor Suppressor Protein p53
|
pubmed:year |
2010
|
pubmed:articleTitle |
14-3-3 sigma and p53 expression in gastric cancer and its clinical applications.
|
pubmed:affiliation |
Center of Operative Medicine, Department of Visceral, Transplant and Thoracic Surgery, Innsbruck Medical University, Anichstrasse 35, Innsbruck, Austria. gilbert.muehlmann@imed.ac.at
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|